🎉 M&A multiples are live!
Check it out!

GH Research Valuation Multiples

Discover revenue and EBITDA valuation multiples for GH Research and similar public comparables like Vivoryon Therapeutics, Benevolent AI, and Galapagos.

GH Research Overview

About GH Research

GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.


Founded

2021

HQ

United States of America
Employees

50

Website

ghres.com

Financials

LTM Revenue n/a

LTM EBITDA -$52.2M

EV

$415M

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 10K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

GH Research Financials

GH Research has a last 12-month revenue of n/a and a last 12-month EBITDA of -$52.2M.

In the most recent fiscal year, GH Research achieved revenue of n/a and an EBITDA of -$38.6M.

GH Research expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See GH Research valuation multiples based on analyst estimates

GH Research P&L

FY 2023 FY 2024 FY 2025 LTM NTM
Revenue n/a n/a XXX XXX XXX
Gross Profit n/a n/a XXX XXX XXX
Gross Margin NaN% NaN% XXX XXX XXX
EBITDA -$35.2M -$38.6M XXX XXX XXX
EBITDA Margin -Infinity% -Infinity% XXX XXX XXX
Net Profit -$22.5M -$35.6M XXX XXX XXX
Net Margin -Infinity% -Infinity% XXX XXX XXX
Net Debt n/a n/a XXX XXX XXX

Financial data powered by Morningstar, Inc.

GH Research Stock Performance

As of April 15, 2025, GH Research's stock price is $9.

GH Research has current market cap of $564M, and EV of $415M.

See GH Research trading valuation data

GH Research Stock Data

EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$415M $564M XXX XXX XXX XXX $-0.82

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Sign Up

GH Research Valuation Multiples

As of April 15, 2025, GH Research has market cap of $564M and EV of $415M.

GH Research's trades at n/a LTM EV/Revenue multiple, and -8.0x LTM EBITDA.

Analysts estimate GH Research's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See valuation multiples for GH Research and 10K+ public comps

GH Research Financial Valuation Multiples

FY 2024 FY 2025E FY 2026E FY 2027E
EV $415M XXX XXX XXX
EV/Revenue n/a XXX XXX XXX
EV/EBITDA -10.8x XXX XXX XXX
P/E -14.5x XXX XXX XXX
P/E/Growth n/a XXX XXX XXX
EV/FCF -9.8x XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get GH Research Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Sign Up

GH Research Valuation Multiples

GH Research's NTM/LTM revenue growth is n/a

GH Research's revenue per employee for the last fiscal year averaged n/a, while opex per employee averaged $1.0M for the same period.

Over next 12 months, GH Research's ratio of sales and marketing spend to revenue is estimated to be  XXX , while its R&D spend to revenue to be  XXX .

Analysts estimate GH Research's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See operational valuation multiples for GH Research and other 10K+ public comps

GH Research Operational Valuation Multiples

FY 2024 NTM FY 2025E FY 2026E FY 2027E
Revenue Growth n/a XXX XXX XXX XXX
EBITDA Margin n/a XXX XXX XXX XXX
EBITDA Growth 10% XXX XXX XXX XXX
Rule of 40 (SaaS-only) n/a XXX XXX XXX XXX
Revenue per Employee n/a XXX XXX XXX XXX
Opex per Employee $1.0M XXX XXX XXX XXX
S&M Expenses to Revenue n/a XXX XXX XXX XXX
G&A Expenses to Revenue n/a XXX XXX XXX XXX
R&D Expenses to Revenue n/a XXX XXX XXX XXX
Opex to Revenue n/a XXX XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Developer Tools
Consumer SaaS
Streaming Platforms

GH Research Public Comps

See public comps and valuation multiples for Drug Development & Therapeutics comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Julphar XXX XXX XXX XXX XXX XXX
Benevolent AI XXX XXX XXX XXX XXX XXX
Galapagos XXX XXX XXX XXX XXX XXX
Pharming XXX XXX XXX XXX XXX XXX
Vivoryon Therapeutics XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

GH Research M&A and Investment Activity

GH Research acquired  XXX companies to date.

Last acquisition by GH Research was  XXXXXXXX, XXXXX XXXXX XXXXXX . GH Research acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by GH Research

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.

Sign Up

About GH Research

When was GH Research founded? GH Research was founded in 2021.
Where is GH Research headquartered? GH Research is headquartered in United States of America.
How many employees does GH Research have? As of today, GH Research has 50 employees.
Who is the CEO of GH Research? GH Research's CEO is Dr. Velichka Valcheva, M.D.,M.Sc..
Is GH Research publicy listed? Yes, GH Research is a public company listed on NAS.
What is the stock symbol of GH Research? GH Research trades under GHRS ticker.
When did GH Research go public? GH Research went public in 2021.
Who are competitors of GH Research? Similar companies to GH Research include e.g. Julphar, Benevolent AI, Galapagos, Pharming.
What is the current market cap of GH Research? GH Research's current market cap is $564M
What is the current EBITDA of GH Research? GH Research's last 12-month EBITDA is -$52.2M.
What is the current EV/EBITDA multiple of GH Research? Current EBITDA multiple of GH Research is -8.0x.
Is GH Research profitable? Yes, GH Research is EBITDA-positive (as of the last 12 months).

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.